Document:

crda-ex1026_680.htm

 

Exhibit 10.26

 

Director Compensation Summary Term Sheet

 

During calendar year 2020, each non-employee member of the Board was entitled to receive an aggregate of $140,000 in cash and restricted stock. The cash portion of the compensation was paid quarterly in $12,500 increments. The remainder of such compensation was paid in restricted shares of the Company’s Class A common stock, and vested on December 31, 2020 to individuals who were on the Board on December 31, 2020.

 

In addition to the foregoing, for 2020 each non-employee director was entitled to receive $1,500 for each Board or committee meeting attended. Further, the Chairman of each of the Executive Committee, the Governance Committee, and the Compensation Committee was paid an additional retainer of $2,500 per quarter. The Chairman of the Audit Committee was paid a retainer of $4,250 per quarter. In addition to the amounts set forth above, the Chairman of the Board was entitled to receive (i) a retainer of $100,000, payable quarterly in restricted shares of the Company’s Class A Common Stock pursuant to the terms of the Crawford & Company Non-Employee Director Stock Plan.

 

During calendar year 2021, each non-employee member of the Board is entitled to receive an aggregate of $140,000 in cash and restricted stock. The cash portion of the compensation will be paid quarterly in $12,500 increments. The remainder of such compensation will be paid in restricted shares of the Company’s Class A common stock, and will vest on December 31, 2021 to individuals who are on the Board on December 31, 2021.

 

In addition to the foregoing, for 2021 each non-employee director is entitled to receive $1,500 for each Board or committee meeting attended. Further, the Chairman of each of the Executive Committee, the Governance Committee, and the Compensation Committee is paid an additional retainer of $2,500 per quarter. The Chairman of the Audit Committee is paid a retainer of $4,250 per quarter. In addition to the amounts set forth above, the Chairman of the Board is entitled to receive a retainer of $100,000, payable quarterly in restricted shares of the Company’s Class A Common Stock pursuant to the terms of the Crawford & Company Non-Employee Director Stock Plan.Exhibit 4.1

SPECIMEN UNIT CERTIFICATE 

 

NUMBER UNITS U- 

	
        SEE REVERSE FOR

        

        CERTAIN

        

        DEFINITIONS

        
	 	European Biotech Acquisition Corp.	 	 

CUSIP [●] 

 

UNITS CONSISTING OF ONE CLASS A ORDINARY
SHARE AND ONE-THIRD OF ONE 

REDEEMABLE 

 

WARRANT TO PURCHASE ONE CLASS A ORDINARY
SHARE 

 

THIS CERTIFIES THAT is the owner of Units.

 

Each Unit (“Unit”) consists of one (1) Class A ordinary
share, par value $0.0001 per share (“Ordinary Shares”), of European Biotech Acquisition Corp., a Cayman Islands exempted
company (the “Company”), and one-third (1/3) of one redeemable warrant (each whole warrant, a “Warrant”).
Each Warrant entitles the holder to purchase one (1) Ordinary Share for $11.50 per share (subject to adjustment). Each Warrant
will become exercisable on the later of (i) thirty (30) days after the Company’s completion of a merger, share exchange,
asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses (each, a “Business
Combination”), and (ii) twelve (12) months from the closing of the Company’s initial public offering, and will expire
unless exercised before 5:00 p.m., New York City Time, on the date that is five (5) years after the date on which the Company completes
its initial Business Combination, or earlier upon redemption or liquidation (the “Expiration Date”). The Ordinary Shares
and Warrants comprising the Units represented by this certificate are not transferable separately prior to [●], 2021, unless
Credit Suisse Securities (USA) LLC and Kempen & Co. U.S.A., Inc. elect to allow earlier separate trading, subject to the Company’s
filing with the Securities and Exchange Commission of a Current Report on Form 8-K containing an audited balance sheet reflecting
the Company’s receipt of the gross proceeds of the initial public offering and issuing a press release announcing when separate
trading will begin. No fractional warrants will be issued upon separation of the Units and only warrant are exerciseable. The terms
of the Warrants are governed by a Warrant Agreement, dated as of [●], 2021, between the Company and Continental Stock Transfer
& Trust Company, as Warrant Agent, and are subject to the terms and provisions contained therein, all of which terms and provisions
the holder of this certificate consents to by acceptance hereof. Copies of the Warrant Agreement are on file at the office of the
Warrant Agent at 1 State Street, 30th Floor, New York, New York 10004, and are available to any Warrant holder on written request
and without cost.

 

Upon the consummation of the Business Combination, the Units
represented by this certificate will automatically separate into the Class A Ordinary Shares and Warrants comprising such Units.

 

This certificate is not valid unless countersigned by the Transfer
Agent and Registrar of the Company.

 

This certificate shall be governed by and construed in accordance
with the internal laws of the State of New York.

 

Witness the facsimile signatures of its duly authorized officers.

	 	 	 	 	 
	By	 	 	 	 
	 	 	Chief Executive Officer	 	Chief Financial Officer

     

     

    

European Biotech Acquisition Corp. 

 

The Company will furnish without charge to each unitholder who
so requests, a statement of the powers, designations, preferences and relative, participating, optional or other special rights
of each class of shares or series thereof of the Company and the qualifications, limitations or restrictions of such preferences
and/or rights.

 

The following abbreviations, when used in the inscription on
the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:

 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
        TEN

        

        COM

         
	 	—	 	as tenants in common	 	
        UNIF GIFT

        

        MIN ACT

         
	 	—	 	 	 	Custodian	 	 
	 	 	 	 	 	 	 	 	 	 	(Cust)	 	 	 	(Minor)
	 	 	 	 	 	 	 	 	 
	
        TEN

        

        ENT

        
	 	—	 	as tenants by the entireties	 	 	 	 	 	
        under Uniform Gifts to

        

        Minors Act

        

	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	(State)
	JT TEN	 	—	 	as joint tenants with right of survivorship and not as tenants in common	 	 	 	 	 	 	 	 	 	 

 

Additional abbreviations may also be used though not in the
above list.

 

For value received, hereby sells, assigns and transfers unto

 

PLEASE INSERT SOCIAL SECURITY OR OTHER IDENTIFYING
NUMBER OF ASSIGNEE

 

(PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS,
INCLUDING ZIP CODE, OF ASSIGNEE)

 

Units represented by the within Certificate, and do hereby irrevocably
constitute and appoint Attorney to transfer the said Units on the books of the within named Company with full power of substitution
in the premises.

 

	 	 	 	 	 
	 	 	 	 	 
	Dated  	 	 	 	 
	 	 	Notice: The signature to this assignment must correspond with the name as written upon the face of the certificate in every particular, without alteration or enlargement or any change whatever.
	Signature(s) Guaranteed:	 	 
	THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 OR ANY SUCCESSOR RULES).	 	 

     

     

    

In each case, as more fully described in the
Company’s final prospectus dated [●], 2021, the holder(s) of this certificate shall be entitled to receive a
pro-rata portion of certain funds held in the trust account established in connection with the Company’s initial public
offering only in the event that (i) the Company redeems the Ordinary Shares sold in its initial public offering and
liquidates because it does not consummate an initial business combination within the period of time set forth in the
Company’s amended and restated memorandum and articles of association, as the same may be amended from time to time,
(ii) the Company redeems the Ordinary Shares sold in its initial public offering in connection with a shareholder vote to
amend the Company’s amended and restated memorandum and articles of association (A) that would modify the substance or
timing of the Company’s obligation to provide holders of the Ordinary Shares the right to have their shares redeemed in
connection with the Company’s initial business combination or to redeem 100% of the Ordinary Shares if the Company does
not complete its initial business combination within the time period set forth therein or (B) with respect to any other
provision relating to the rights of holders of the Ordinary Shares, or (iii) if the holder(s) seek(s) to redeem for cash his,
her or its respective Ordinary Shares in connection with a tender offer (or proxy solicitation, solely in the event the
Company seeks shareholder approval of the proposed initial business combination) setting forth the details of a proposed
initial business combination. In no other circumstances shall the holder(s) have any right or interest of any kind in or to
the trust account.Exhibit 4.2

 

SPECIMEN CLASS A ORDINARY SHARE CERTIFICATE

 

	 	 	 
	NUMBER	 	SHARES

 

EUROPEAN BIOTECH ACQUISITION CORP.  

INCORPORATED UNDER THE LAWS OF THE CAYMAN
ISLANDS  

CLASS A ORDINARY SHARES 

 

SEE REVERSE FOR 

CERTAIN DEFINITIONS 

 

CUSIP [ ] 

 

This Certifies that is the owner of 

 

FULLY PAID AND NON-ASSESSABLE CLASS A
ORDINARY SHARES OF THE PAR VALUE OF US$0.0001 EACH OF EUROPEAN BIOTECH ACQUISITION CORP. (THE “COMPANY”) 

 

Subject to the Company’s amended
and restated memorandum and articles of association, as the same may be amended from time to time, and transferable on the books
of the Company in person or by duly authorized attorney upon surrender of this certificate properly endorsed. 

 

The Company will be forced to redeem
all of its Class A ordinary shares if it is unable to complete a business combination within the period set forth in the Company’s
amended and restated memorandum and articles of association, as the same may be amended from time to time, all as more fully described
in the Company’s final prospectus dated [●], 2021. 

 

This certificate is not valid unless
countersigned by the Transfer Agent and registered by the Registrar. 

 

Witness the facsimile signatures of its
duly authorized officers. 

 

	 
	Dated:

	 	 	 	 	 
	Chief Executive Officer	 	Cayman Islands	 	Chief Financial Officer

 

    

     

    

EUROPEAN BIOTECH ACQUISITION CORP.

 

The Company will furnish without charge to each shareholder
who so requests the powers, designations, preferences and relative, participating, optional or other special rights of each class
of shares or series thereof of the Company and the qualifications, limitations, or restrictions of such preferences and/or rights.
This certificate and the shares represented thereby are issued and shall be held subject to all the provisions of the Company’s
amended and restated memorandum and articles of association, as the same may be amended from time to time, and resolutions of the
Board of Directors providing for the issue of Class A ordinary shares (copies of which may be obtained from the secretary of the
Company), to all of which the holder of this certificate by acceptance hereof assents. The following abbreviations, when used in
the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable
laws or regulations:

 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
        TEN

        

        COM

         
	 	—	 	as tenants in common	 	
        UNIF GIFT

        

        MIN ACT

         
	 	—	 	 	 	 	 	 	Custodian	 	 	 	 	 
	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	(Cust	) 	 	 	 	 	 	 	(Minor	) 
	 	 	 	 	 	 
	
        TEN

        

        ENT

         
	 	—	 	as tenants by the entireties	 	 	 	 	 	 	under Uniform Gifts to

Minors Act	 
	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	(State)	 
	 	 	 	 	 	 	 	 
	JT TEN	 	—	 	as joint tenants with right of survivorship and not as tenants in common	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

 

Additional abbreviations may also be used though not in the
above list.

 

For value received, hereby sells, assigns and transfers unto

 

(PLEASE INSERT SOCIAL SECURITY OR OTHER
IDENTIFYING NUMBER(S) OF ASSIGNEE(S))

 

(PLEASE PRINT OR TYPEWRITE NAME(S) AND ADDRESS(ES),
INCLUDING ZIP CODE, OF ASSIGNEE(S))

 

Shares represented by the within Certificate, and does hereby
irrevocably constitute and appoint Attorney to transfer the said shares on the books of the within named Company with full power
of substitution in the premises.

 

	 	 	 
	Dated:	 	 
	 	 
	 	 	Shareholder
	 	 
	 	 	NOTICE: THE SIGNATURE(S) TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT OR ANY CHANGE WHATEVER.
	 	 
	Signature(s) Guaranteed:	 	 
	 	 
	By	 	 
	 	 
	 	 	 
	 	 
	 	 	 

    2 

     

    

THE SIGNATURE(S) MUST BE GUARANTEED BY AN ELIGIBLE GUARANTOR
INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE
MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 OR ANY SUCCESSOR RULE).

 

In each case, as more fully described in the Company’s
final prospectus dated [●], 2021, the holder(s) of this certificate shall be entitled to receive a pro-rata portion of certain
funds held in the trust account established in connection with its initial public offering only in the event that (i) the Company
redeems the Class A ordinary shares sold in its initial public offering and liquidates because it does not consummate an initial
business combination within the period of time set forth in the Company’s amended and restated memorandum and articles of
association, as the same may be amended from time to time, (ii) the Company redeems the Class A ordinary shares sold in its initial
public offering in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles
of association (A) that would modify the substance or timing of the Company’s obligation to provide holders of the Class
A ordinary shares the right to have their shares redeemed in connection with the Company’s initial business combination or
to redeem 100% of the Class A ordinary shares if the Company does not complete its initial business combination within the time
period set forth therein or (B) with respect to any other provision relating to the rights of holders of the Class A ordinary shares,
or (iii) if the holder(s) seek(s) to redeem for cash his, her or its respective Class A ordinary shares in connection with a tender
offer (or proxy solicitation, solely in the event the Company seeks shareholder approval of the proposed initial business combination)
setting forth the details of a proposed initial business combination. In no other circumstances shall the holder(s) have any right
or interest of any kind in or to the trust account.

 

 

 

    3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00323-of-00352.parquet"}]]